Physician_Profile_ID,Category,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID,Total_Amount_of_Payment_USDollars,Date_of_Payment,Category,Record_ID
12,GNRL,"Purdue Pharma L.P.",CT,100000005432,6270.00,11/07/2015,GNRL,251160524
12,GNRL,"Purdue Pharma L.P.",CT,100000005432,1980.00,03/26/2015,GNRL,251008192
12,GNRL,"Purdue Pharma L.P.",CT,100000005432,1980.00,03/12/2015,GNRL,251006408
12,GNRL,"Purdue Pharma L.P.",CT,100000005432,1980.00,02/26/2015,GNRL,251004418
12,GNRL,"Purdue Pharma L.P.",CT,100000005432,1650.00,03/23/2015,GNRL,251007296
12,GNRL,"Purdue Pharma L.P.",CT,100000005432,1650.00,04/14/2015,GNRL,251013498
12,GNRL,"Purdue Pharma L.P.",CT,100000005432,1650.00,05/27/2015,GNRL,251012772
12,GNRL,"Purdue Pharma L.P.",CT,100000005432,1485.00,03/25/2015,GNRL,251007858
12,GNRL,"Purdue Pharma L.P.",CT,100000005432,1402.50,03/04/2015,GNRL,251008764
12,GNRL,"Purdue Pharma L.P.",CT,100000005432,1402.50,09/10/2015,GNRL,251116750
12,GNRL,"Purdue Pharma L.P.",CT,100000005432,925.20,01/14/2015,GNRL,251157418
12,GNRL,"Purdue Pharma L.P.",CT,100000005432,477.60,11/02/2015,GNRL,251157994
12,GNRL,"Purdue Pharma L.P.",CT,100000005432,381.60,11/02/2015,GNRL,251157996
12,GNRL,"Purdue Pharma L.P.",CT,100000005432,210.21,03/12/2015,GNRL,251112630
12,GNRL,"Purdue Pharma L.P.",CT,100000005432,204.70,03/26/2015,GNRL,251112634
12,GNRL,"Purdue Pharma L.P.",CT,100000005432,159.85,01/18/2015,GNRL,251156972
12,GNRL,"Purdue Pharma L.P.",CT,100000005432,159.85,11/06/2015,GNRL,251158104
12,GNRL,"Purdue Pharma L.P.",CT,100000005432,141.23,11/07/2015,GNRL,251157738
12,GNRL,"Purdue Pharma L.P.",CT,100000005432,122.46,01/18/2015,GNRL,251157124
12,GNRL,"Purdue Pharma L.P.",CT,100000005432,120.31,11/07/2015,GNRL,251157836
12,GNRL,"Purdue Pharma L.P.",CT,100000005432,120.31,11/06/2015,GNRL,251157928
12,GNRL,"Purdue Pharma L.P.",CT,100000005432,116.15,02/26/2015,GNRL,251112666
12,GNRL,"Depomed, Inc.",CA,100000000324,108.87,08/21/2013,GNRL,220421858
12,GNRL,"Purdue Pharma L.P.",CT,100000005432,101.89,03/23/2015,GNRL,251112632
12,GNRL,"Purdue Pharma L.P.",CT,100000005432,94.21,05/27/2015,GNRL,251012770
12,GNRL,"Pfizer Inc.",NY,100000000286,87.03,05/15/2014,GNRL,206948208
12,GNRL,"Pfizer Inc.",NY,100000000286,82.18,05/12/2015,GNRL,323165681
12,GNRL,"Purdue Pharma L.P.",CT,100000005432,80.96,05/27/2015,GNRL,251112650
12,GNRL,"Purdue Pharma L.P.",CT,100000005432,80.32,01/19/2015,GNRL,251157356
12,GNRL,"Purdue Pharma L.P.",CT,100000005432,80.32,01/18/2015,GNRL,251157248
12,GNRL,"Purdue Transdermal Technologies L.P.",CT,100000005455,75.58,09/18/2013,GNRL,103079798
12,GNRL,"Purdue Pharma L.P.",CT,100000005432,71.95,03/26/2015,GNRL,251008190
12,GNRL,"Purdue Pharma L.P.",CT,100000005432,70.76,03/23/2015,GNRL,251007300
12,GNRL,"Purdue Pharma L.P.",CT,100000005432,65.44,04/14/2015,GNRL,251112644
12,GNRL,"Boston Scientific Corporation",MA,100000005674,65.31,11/22/2013,GNRL,101911302
12,GNRL,"Amendia, Inc.",GA,100000011196,63.38,05/29/2014,GNRL,221487056
12,GNRL,"Purdue Pharma L.P.",CT,100000005432,62.37,02/26/2015,GNRL,251004420
12,GNRL,"Purdue Pharma L.P.",CT,100000005432,50.47,03/12/2015,GNRL,251006406
12,GNRL,"Purdue Pharma L.P.",CT,100000005432,47.72,03/25/2015,GNRL,251007852
12,GNRL,"Purdue Pharma L.P.",CT,100000005432,44.29,03/02/2015,GNRL,251006820
12,GNRL,"Amendia, Inc.",GA,100000011196,43.67,08/28/2014,GNRL,221487070
12,GNRL,"Stryker Corporation",MI,100000010503,39.41,12/04/2013,GNRL,29860430
12,GNRL,"Purdue Pharma L.P.",CT,100000005432,37.89,04/14/2015,GNRL,251013500
12,GNRL,"Purdue Pharma L.P.",CT,100000005432,35.26,09/10/2015,GNRL,251116752
12,GNRL,"Stryker Corporation",MI,100000010503,32.26,09/05/2014,GNRL,198898524
12,GNRL,"Boston Scientific Corporation",MA,100000005674,28.00,12/18/2013,GNRL,101911298
12,GNRL,"Stryker Corporation",MI,100000010503,27.45,08/20/2015,GNRL,324507068
12,GNRL,"XenoPort Inc.",CA,100000000275,25.00,08/10/2015,GNRL,322025446
12,GNRL,"Boston Scientific Corporation",MA,100000005674,23.02,05/02/2014,GNRL,153293850
12,GNRL,"Allergan Inc.",CA,100000000278,20.94,10/16/2013,GNRL,102507182
12,GNRL,"Purdue Pharma L.P.",CT,100000005432,20.69,07/14/2015,GNRL,251106436
12,GNRL,"Purdue Pharma L.P.",CT,100000005432,20.63,07/21/2014,GNRL,158206956
12,GNRL,"Amendia, Inc.",GA,100000011196,20.35,05/30/2014,GNRL,221487060
12,GNRL,"Amendia, Inc.",GA,100000011196,20.18,06/03/2014,GNRL,221487064
12,GNRL,"Medtronic USA, Inc.",MN,100000010383,19.67,01/08/2014,GNRL,140610896
12,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,19.49,05/12/2014,GNRL,188602960
12,GNRL,"XenoPort Inc.",CA,100000000275,19.24,11/10/2015,GNRL,322025458
12,GNRL,"Boston Scientific Corporation",MA,100000005674,19.21,04/29/2014,GNRL,153293844
12,GNRL,"Merz North America, Inc.",NC,100000005376,18.73,09/25/2014,GNRL,202901596
12,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,18.73,12/14/2015,GNRL,260084048
12,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,18.70,06/04/2015,GNRL,260076462
12,GNRL,"XenoPort Inc.",CA,100000000275,18.33,04/02/2015,GNRL,322025442
12,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,18.23,08/27/2015,GNRL,326242396
12,GNRL,"Boston Scientific Corporation",MA,100000005674,17.94,01/07/2015,GNRL,246090178
12,GNRL,"XenoPort Inc.",CA,100000000275,17.00,07/21/2015,GNRL,322025450
12,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,16.59,08/13/2015,GNRL,260054448
12,GNRL,"Pfizer Inc.",NY,100000000286,16.56,12/02/2013,GNRL,205568432
12,GNRL,"XenoPort Inc.",CA,100000000275,16.50,10/27/2014,GNRL,201375466
12,GNRL,"Amendia, Inc.",GA,100000011196,16.48,07/17/2014,GNRL,221487068
12,GNRL,"Purdue Pharma L.P.",CT,100000005432,15.95,10/22/2015,GNRL,251132328
12,GNRL,"BIOVENTUS LLC",NC,100000000302,15.78,08/26/2013,GNRL,102294176
12,GNRL,"Purdue Pharma L.P.",CT,100000005432,15.59,11/17/2014,GNRL,158206958
12,GNRL,"Purdue Pharma L.P.",CT,100000005432,15.40,10/14/2013,GNRL,103062368
12,GNRL,"Mallinckrodt LLC",MO,100000005429,15.34,04/09/2014,GNRL,210954940
12,GNRL,"Purdue Pharma L.P.",CT,100000005432,15.22,12/02/2015,GNRL,251151816
12,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,15.15,04/30/2015,GNRL,260127570
12,GNRL,"Purdue Pharma L.P.",CT,100000005432,15.03,08/11/2015,GNRL,251021842
12,GNRL,"Allergan Inc.",CA,100000000278,15.02,08/25/2014,GNRL,203612996
12,GNRL,"LILLY USA, LLC",IN,100000000066,14.96,11/20/2013,GNRL,4682411
12,GNRL,"Allergan Inc.",CA,100000000278,14.81,08/15/2013,GNRL,102507180
12,GNRL,"Pfizer Inc.",NY,100000000286,14.81,03/12/2014,GNRL,206758462
12,GNRL,"Boston Scientific Corporation",MA,100000005674,14.81,04/16/2015,GNRL,246090180
12,GNRL,"Pfizer Inc.",NY,100000000286,14.39,04/13/2015,GNRL,323886352
12,GNRL,"Pernix Therapeutics Holdings, Inc.",NJ,100000010853,14.31,11/30/2015,GNRL,340688956
12,GNRL,"BOSTON SCIENTIFIC CORPORATION",MA,100000005674,14.09,11/03/2014,GNRL,227709720
12,GNRL,"Purdue Pharma L.P.",CT,100000005432,13.93,09/15/2015,GNRL,251119740
12,GNRL,"Boston Scientific Corporation",MA,100000005674,13.72,08/03/2015,GNRL,246090176
12,GNRL,"Purdue Pharma L.P.",CT,100000005432,13.67,10/15/2015,GNRL,251128034
12,GNRL,"Pernix Therapeutics Holdings, Inc.",NJ,100000010853,13.57,07/23/2015,GNRL,340688952
12,GNRL,"Allergan Inc.",CA,100000000278,13.55,03/04/2014,GNRL,203612992
12,GNRL,"Purdue Pharma L.P.",CT,100000005432,13.33,03/03/2015,GNRL,251045120
12,GNRL,"Medtronic Sofamor Danek USA, Inc.",MN,100000010386,13.26,06/09/2015,GNRL,298768212
12,GNRL,"Eisai Inc.",NJ,100000000136,12.92,09/22/2014,GNRL,184466028
12,GNRL,"Medtronic Sofamor Danek USA, Inc.",MN,100000010386,12.91,08/21/2013,GNRL,12876433
12,GNRL,"XenoPort Inc.",CA,100000000275,12.86,09/28/2015,GNRL,322025454
12,GNRL,"Medtronic Sofamor Danek USA, Inc.",MN,100000010386,12.70,09/23/2013,GNRL,12876434
12,GNRL,"Pernix Therapeutics Holdings, Inc.",NJ,100000010853,12.69,06/16/2015,GNRL,340688950
12,GNRL,"Purdue Pharma L.P.",CT,100000005432,12.40,05/05/2015,GNRL,251076458
12,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,12.24,07/16/2015,GNRL,260115670
12,GNRL,"LILLY USA, LLC",IN,100000000066,12.08,11/04/2014,GNRL,137947382
12,GNRL,"Bioventus LLC",NC,100000000302,12.02,08/19/2015,GNRL,311862670
12,GNRL,"Depomed, Inc.",CA,100000000324,11.81,10/02/2013,GNRL,220428628
12,GNRL,"Depomed, Inc.",CA,100000000324,11.62,07/30/2014,GNRL,204820342
12,GNRL,"Allergan Inc.",CA,100000000278,11.60,08/18/2015,GNRL,288769574
12,GNRL,"Purdue Pharma L.P.",CT,100000005432,11.42,11/17/2015,GNRL,251145544
12,GNRL,"Allergan Inc.",CA,100000000278,11.35,12/02/2014,GNRL,203613010
12,GNRL,"LILLY USA, LLC",IN,100000000066,11.34,07/09/2014,GNRL,137816174
12,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,11.33,11/02/2015,GNRL,260081958
12,GNRL,"Pernix Therapeutics Holdings, Inc.",NJ,100000010853,11.25,10/14/2015,GNRL,340688954
12,GNRL,"Allergan Inc.",CA,100000000278,11.18,03/02/2015,GNRL,288571490
12,GNRL,"Bioventus LLC",NC,100000000302,11.12,03/17/2014,GNRL,214116850
12,GNRL,"Horizon Pharma plc","",100000131389,11.09,03/19/2015,GNRL,281893790
12,GNRL,"Depomed, Inc.",CA,100000000324,11.01,06/29/2015,GNRL,282351146
12,GNRL,"Horizon Pharma USA, Inc.",IL,100000005713,10.70,08/27/2013,GNRL,21241194
12,GNRL,"Boston Scientific Corporation",MA,100000005674,10.69,09/12/2013,GNRL,101911300
12,GNRL,"Purdue Pharma L.P.",CT,100000005432,10.65,03/30/2015,GNRL,251060106
12,GNRL,"Mallinckrodt LLC",MO,100000005429,10.64,04/28/2014,GNRL,210954942
12,GNRL,"Lilly USA, LLC",IN,100000000066,10.63,03/17/2015,GNRL,267680170
12,GNRL,"Purdue Pharma L.P.",CT,100000005432,10.57,09/16/2013,GNRL,103062366
12,GNRL,"Teva Pharmaceuticals USA, Inc.",PA,100000000141,10.49,12/16/2013,GNRL,102144498
12,GNRL,"Depomed, Inc.",CA,100000000324,10.46,11/13/2013,GNRL,220425910
12,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,10.44,09/05/2013,GNRL,103237610
12,GNRL,"Horizon Pharma plc","",100000131389,10.43,10/20/2015,GNRL,281893792
12,GNRL,"Boston Scientific Corporation",MA,100000005674,10.41,08/06/2014,GNRL,153293838
12,GNRL,"Pfizer Inc.",NY,100000000286,10.35,10/29/2015,GNRL,322346852
12,GNRL,"Medtronic Sofamor Danek USA, Inc.",MN,100000010386,10.33,09/05/2013,GNRL,12876432
12,GNRL,"Purdue Pharma L.P.",CT,100000005432,10.23,06/15/2015,GNRL,251096188
12,GNRL,"Purdue Pharma L.P.",CT,100000005432,10.01,03/04/2015,GNRL,251112628
12,GNRL,"Purdue Pharma L.P.",CT,100000005432,9.99,02/05/2015,GNRL,251029104
12,GNRL,"LILLY USA, LLC",IN,100000000066,9.87,09/17/2013,GNRL,4684543
12,GNRL,"Allergan Inc.",CA,100000000278,9.36,09/08/2014,GNRL,203613004
12,GNRL,"Pfizer Inc.",NY,100000000286,9.11,08/25/2015,GNRL,322387446
12,GNRL,"Depomed, Inc.",CA,100000000324,9.04,08/13/2013,GNRL,220426376
12,GNRL,"Allergan Inc.",CA,100000000278,7.65,12/03/2014,GNRL,203613006
12,GNRL,"Allergan Inc.",CA,100000000278,5.84,08/09/2013,GNRL,102507178
12,GNRL,"LILLY USA, LLC",IN,100000000066,5.66,08/19/2013,GNRL,4726435
12,GNRL,"LILLY USA, LLC",IN,100000000066,4.69,09/17/2013,GNRL,4683843
12,GNRL,"LILLY USA, LLC",IN,100000000066,4.41,08/19/2013,GNRL,4726079
12,GNRL,"Allergan Inc.",CA,100000000278,3.46,09/08/2014,GNRL,203613000
12,GNRL,"Allergan Inc.",CA,100000000278,3.21,08/25/2014,GNRL,203612998
12,GNRL,"LILLY USA, LLC",IN,100000000066,3.12,11/17/2013,GNRL,4679834
12,GNRL,"Allergan Inc.",CA,100000000278,2.69,12/16/2014,GNRL,203613014
12,GNRL,"Depomed, Inc.",CA,100000000324,2.28,10/02/2013,GNRL,220426680
12,GNRL,"Depomed, Inc.",CA,100000000324,2.26,08/13/2013,GNRL,220424904
12,GNRL,"Pfizer Inc.",NY,100000000286,2.03,08/25/2015,GNRL,322867908
12,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,1.92,09/04/2013,GNRL,103237612
12,GNRL,"Purdue Pharma L.P.",CT,100000005432,1.77,05/05/2015,GNRL,251076456
12,GNRL,"Purdue Pharma L.P.",CT,100000005432,1.71,03/30/2015,GNRL,251060104
12,GNRL,"Pfizer Inc.",NY,100000000286,1.58,04/13/2015,GNRL,323136066
12,GNRL,"Purdue Pharma L.P.",CT,100000005432,1.55,08/11/2015,GNRL,251021840
12,GNRL,"Purdue Pharma L.P.",CT,100000005432,1.55,07/14/2015,GNRL,251106434
12,GNRL,"Purdue Pharma L.P.",CT,100000005432,1.55,06/15/2015,GNRL,251096186
12,GNRL,"Pfizer Inc.",NY,100000000286,1.32,10/29/2015,GNRL,322763868
12,GNRL,"Purdue Pharma L.P.",CT,100000005432,1.24,02/05/2015,GNRL,251029106
12,GNRL,"Purdue Pharma L.P.",CT,100000005432,1.02,03/03/2015,GNRL,251045118
12,GNRL,"Purdue Pharma L.P.",CT,100000005432,0.69,09/15/2015,GNRL,251119744
